4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

In the year 2024, 4D Molecular Therapeutics had annual revenue of $37.00K, down -99.82%. 4D Molecular Therapeutics had revenue of $1,000.00 in the quarter ending December 31, 2024, a decrease of -105.26%.

• Revenue (ttm): $37.00K
• Revenue Growth: -99.82%
• P/S Ratio: 4,191.62
• Revenue / Employee: $163
• Employees: 227
• Market Cap: 147.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.